← Back to Search

Behavioural Intervention

NuvoAir Clinical Service for COPD (PROMISE Trial)

N/A
Recruiting
Led By Jeffrey VanWormer, PHD
Research Sponsored by NuvoAir Medical PC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Are age ≥30 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at whether using the NuvoAir clinical service can help reduce the number of severe COPD exacerbations, hospitalizations, emergency room visits, and overall cost of care for people with

Who is the study for?
This trial is for people over 30 years old with COPD, including conditions like emphysema and chronic bronchitis. Participants must have been diagnosed in the last two years and need access to a smartphone or telephone.
What is being tested?
The study tests if the NuvoAir Clinical Service can reduce severe flare-ups, hospital visits, emergency room trips, and overall costs of care for COPD patients compared to those not using this service over a period of 12 months.
What are the potential side effects?
Since the intervention involves a clinical service rather than medication, traditional side effects are not applicable. However, there may be indirect effects related to changes in disease management.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 30 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Moderate & Severe Exacerbations
Secondary study objectives
Cost of care
Hospital days
Readmissions

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard CareExperimental Treatment0 Interventions
Propensity matched controls with COPD who receive usual care.
Group II: NuvoAir Clinical serviceExperimental Treatment1 Intervention
Patients with COPD receiving usual care plus NuvoAir clinical services.

Find a Location

Who is running the clinical trial?

NuvoAir Medical PCLead Sponsor
1 Previous Clinical Trials
1,050 Total Patients Enrolled
Jeffrey VanWormer, PHDPrincipal InvestigatorMarshfield Clinic
~130 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top